Trial · NCT04005352
Adverse events495
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 495
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Brolucizumab 6mg | 0 | 366 | |
| other | Anaemia | Blood and lymphatic system disorders | Aflibercept 2mg | 4 | 368 | |
| other | Anaemia | Blood and lymphatic system disorders | All Patients | 4 | 734 | |
| other | Atrial fibrillation | Cardiac disorders | Brolucizumab 6mg | 6 | 366 | |
| other | Atrial fibrillation | Cardiac disorders | Aflibercept 2mg | 1 | 368 | |
| other | Atrial fibrillation | Cardiac disorders | All Patients | 7 | 734 | |
| other | Vertigo | Ear and labyrinth disorders | Brolucizumab 6mg | 4 | 366 | |
| other | Vertigo | Ear and labyrinth disorders | Aflibercept 2mg | 4 | 368 | |
| other | Vertigo | Ear and labyrinth disorders | All Patients | 8 | 734 | |
| other | Cataract - Study Eye | Eye disorders | Brolucizumab 6mg | 5 | 366 | |
| other | Cataract - Study Eye | Eye disorders | Aflibercept 2mg | 7 | 368 | |
| other | Cataract - Study Eye | Eye disorders | All Patients | 12 | 734 | |
| other | Choroidal neovascularisation - Fellow Eye | Eye disorders | Brolucizumab 6mg | 5 | 366 | |
| other | Choroidal neovascularisation - Fellow Eye | Eye disorders | Aflibercept 2mg | 7 | 368 | |
| other | Choroidal neovascularisation - Fellow Eye | Eye disorders | All Patients | 12 | 734 | |
| other | Conjunctival haemorrhage - Fellow Eye | Eye disorders | Brolucizumab 6mg | 3 | 366 | |
| other | Conjunctival haemorrhage - Fellow Eye | Eye disorders | Aflibercept 2mg | 4 | 368 | |
| other | Conjunctival haemorrhage - Fellow Eye | Eye disorders | All Patients | 7 | 734 | |
| other | Conjunctival haemorrhage - Study Eye | Eye disorders | Brolucizumab 6mg | 23 | 366 | |
| other | Conjunctival haemorrhage - Study Eye | Eye disorders | Aflibercept 2mg | 13 | 368 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04005352/events